Tevogen Inc. Common Stock
TVGN
64 hedge funds and large institutions have $353M invested in Tevogen Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 11 increasing their positions, 13 reducing their positions, and 8 closing their positions.
25% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 8
10% more capital invested
Capital invested by funds: $323M → $353M (+$30.7M)
3% more funds holding
Funds holding: 62 → 64 (+2)
0.12% more ownership
Funds ownership: 1.78% → 1.9% (+0.12%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
15% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Calamos Advisors
Naperville,
Illinois
|
+$20.5M |
| 2 |
WCMNY
Westchester Capital Management (New York)
Valhalla,
New York
|
+$9.48M |
| 3 |
RCM
Radcliffe Capital Management
Bala Cynwyd,
Pennsylvania
|
+$5.13M |
| 4 |
WAM
Weiss Asset Management
Boston,
Massachusetts
|
+$4.14M |
| 5 |
CCA
Castle Creek Arbitrage
Avon,
Colorado
|
+$4.09M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HCM
Highbridge Capital Management
New York
|
-$9.1M |
| 2 |
Parallax Volatility Advisers
San Francisco,
California
|
-$5.05M |
| 3 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$4.85M |
| 4 |
Citigroup
New York
|
-$4.11M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$3.83M |
TVGN Hedge Fund Activity: Q4 2022 in Review
64 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in Tevogen Inc. Common Stock (TVGN) for Q4 2022, worth a combined $353M — up 9.5% from $323M a quarter earlier.
Buyers outnumbered sellers: 10 funds opened new TVGN positions and 8 closed out — a net gain of 2 holders — while 11 added to existing stakes and 13 trimmed.
The largest buyer was Calamos Advisors, opening a new position worth an estimated $20.5M. The largest seller was Highbridge Capital Management, cutting an estimated $9.1M.
- 64 institutional investors held Tevogen Inc. Common Stock (TVGN) as of Q4 2022, up from 62 in Q3 2022.
- Funds reported $353M of Tevogen Inc. Common Stock stock for Q4 2022, up 9.5% quarter-over-quarter.
- 10 funds opened new Tevogen Inc. Common Stock positions in Q4 2022 and 8 closed out, a net change of +2 holders.
- The largest Tevogen Inc. Common Stock buyer in Q4 2022 was Calamos Advisors, an estimated $20.5M added.
- The largest Tevogen Inc. Common Stock seller in Q4 2022 was Highbridge Capital Management, an estimated $9.1M sold.
Based on aggregated 13F filings for Q4 2022.